| 54 |
Titel |
TI |
[DE] Medizinprodukt mit einer aktiven Beschichtung
[EN] Medical Product Comprising an Active Coating
[FR] Produit médical doté d'un revêtement actif |
| 71/73 |
Anmelder/Inhaber |
PA |
BIOTRONIK AG, CH
|
| 72 |
Erfinder |
IN |
BRAUNE MARLEN, DE
;
GROSCHNER KLAUS, AT
;
WITTCHOW ERIC, DE
|
| 22/96 |
Anmeldedatum |
AD |
29.02.2012 |
| 21 |
Anmeldenummer |
AN |
12157486 |
|
Anmeldeland |
AC |
EP |
|
Veröffentlichungsdatum |
PUB |
19.09.2012 |
33
31
32 |
Priorität |
PRC
PRN
PRD |
US
201161453146
20110316
|
| 51 |
IPC-Hauptklasse |
ICM |
A61L 29/08
(2006.01)
|
| 51 |
IPC-Nebenklasse |
ICS |
A61L 29/16
(2006.01)
A61L 31/02
(2006.01)
A61L 31/10
(2006.01)
A61L 31/16
(2006.01)
|
|
IPC-Zusatzklasse |
ICA |
|
|
IPC-Indexklasse |
ICI |
|
|
Gemeinsame Patentklassifikation |
CPC |
A61L 2300/432
A61L 29/085
A61L 29/16
A61L 31/022
A61L 31/10
A61L 31/16
|
|
MCD-Hauptklasse |
MCM |
A61L 29/08
(2006.01)
|
|
MCD-Nebenklasse |
MCS |
A61L 29/16
(2006.01)
A61L 31/02
(2006.01)
A61L 31/10
(2006.01)
A61L 31/16
(2006.01)
|
|
MCD-Zusatzklasse |
MCA |
|
| 57 |
Zusammenfassung |
AB |
[DE] Die vorliegende Erfindung betrifft ein mit einer Polymerschicht überzogenes Medizinprodukt, welches unter, in und/oder auf der biostabilen und/oder bioabbaubaren Polymerschicht einen Inhibitor des TRPC-3 Ionenkanals aufweist.
[EN] A medical device has a biostable and/or biodegradable polymer layer coated on one or whole portion of surface. The polymer layer contains an inhibitor of TRPC-3 ion channel. An independent claim is included for use of inhibitor of TRPC-3 ion channel. |
| 56 |
Entgegengehaltene Patentdokumente/Zitate,
in Recherche ermittelt |
CT |
WO002005049084A2
WO002009124973A1
|
| 56 |
Entgegengehaltene Patentdokumente/Zitate,
vom Anmelder genannt |
CT |
|
| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
in Recherche ermittelt |
CTNP |
JIN SEOK WOO, CHUNG-HYUN CHO, DO HAN KIM AND EUN HUI LEE: "TRPC3 cation channel plays an important role in profilferation and differentiation of skeletal muscle myoblasts", EXPERIMENTAL AND MOLECULAR MEDICINE, vol. 42, no. 9, September 2010 (2010-09-01), pages 614 - 627, XP002680267 0;
KIYONAKA SHIGEKI ET AL: "Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 106, no. 13, 31 March 2009 (2009-03-31), pages 5400 - 5405, XP008137066, ISSN: 0027-8424, [retrieved on 20090316], DOI: 10.1073/PNAS.0808793106 0;
WORLEY ET AL: "TRPC channels as STIM1-regulated store-operated channels", CELL CALCIUM (EDINBURGH), CHURCHILL LIVINGSTONE MEDICAL JOURNALS, EDINBURGH, GB, vol. 42, no. 2, 10 July 2007 (2007-07-10), pages 205 - 211, XP022136171, ISSN: 0143-4160 0
|
| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt |
CTNP |
JORGENSEN B ET AL.: "Restenosis and Clinical Outcome in Patients Treated With Amlodipine After Angioplasty: Results From the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES", J AM COLL CARDIOL, vol. 35, 2000, pages 592 - 9 1
|
|
Zitierende Dokumente |
|
Dokumente ermitteln
|
|
Sequenzprotokoll |
|
|
|
Prüfstoff-IPC |
ICP |
A61F 2/82
A61L 27/54
A61L 29/08
A61L 29/16
A61L 31/10
A61L 31/16
|
